Cancer World Newsletter - Recent trials in osteosarcoma and their implications for future studies |
|
|
|
Spotlight on: Recent trials in osteosarcoma and their implications for future studies This grandround gives a succinct overview of the management of a cancer most oncologists will come across only rarely. Specialist Stefan Bielack looks at the factors that are important for personalising therapies to maximise survival rates while avoiding unnecessary limb amputations. He explores what needs to be done to improve the prognosis in this disease, where survival rates have not changed since the early 1980s. You can read the full article in Cancer World.
|
|
Cancer World Newsletter - Framing the argument over futile care |
|
|
|
Spotlight on: Framing the argument over futile care This editorial argues that handling the transition from active to palliative care is indeed a weak point in oncology, and if the cancer community fails to address it, we will leave it open to the accountants to set the agenda on futile care You can read the full article in Cancer World.
|
|
Cancer World Newsletter- How are we doing? |
|
|
|
Spotlight on: Systems and Services. How are we doing? The question that could help drive up standards across Europe's cancer services. Who is responsible for setting standards in cancer care and checking on how well the people and institutions charged with caring for cancer patients are doing their job? This Systems and Services article looks at the patchy picture of quality control operating across Europe and asks whether it is fit for purpose. You can read the full article in Cancer World.
|
|
SIOPe Newsletter, Vol. 12, May 2012 |
|
|
|
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) presents the latest version of its newsletter.
Features in the Spring edition 2012 include: - Five years of SIOPE! - ENCCA: overview of achievements to date - International Childhood Cancer Day 2012 - HeadSmart pan-European campaign - Updates on the EU Clinical Trials Directive and Cross-Border Healthcare Directive - Horizon 2020: the next EU-funded research framework programme - SIOPE General Assembly in London, 8 October 2012.
To see the Newsletter, please click here.
|
|
Spotlight on: A world class centre arises from the French ground-zero If you could build a brand new cancer centre, plug it into a dynamic research and development environment and even custom build an interface with every clinic in the region where cancer patients are treated, how would you go about it? Jean-Pierre Armand, a veteran medical oncologist from the Gustave Roussy, is one of the few people ever to be asked that question as more than a hypothetical exercise. This Spotlight article tells the story of how his dreams shaped the new Toulouse University Cancer Hospital, which is set to take its place among Europe's finest when it opens early next year.Cancer World Newsletter - A world class centre arises from the French ground-zero. You can read the full article in Cancer World.
|
|
Award Winning Awareness Campaign for Colorectal Cancer |
|
|
|
A pan-European public awareness campaign about early detection of colorectal cancer by three Austrian students has won the 4th AdVenture student competition organised by EACA (The European Association of Communications Agencies) through its European Foundation for Commercial Communications Education, edcom. The Austrian team's "Don't make excuses" campaign aims to inform people about the necessity and simplicity of preventive colorectal cancer examination, to remove negative prejudices and to show people that making excuses for postponing preventive checkups is not justified. For more information, please see: www.adventure-competition.eu
|
|
4th International Cancer Control Congress |
|
|
|
The 4th ICCC (International Cancer Control Congress) has been scheduled for November 3-5th, 2011 at the National Cancer Center, Seoul, Republic of Korea. This is a bi-annual congress for governmental and non-governmental cancer control officials; for physicians, nurses, researchers and health professionals; and patients, advocates, volunteers and all others interested in cancer control.
|
|
Read more >>
|
|
|
|
Page 12 of 12 |